Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer

Aggarwal, R; Alumkal, JJ; Szmulewitz, RZ; Higano, CS; Bryce, AH; Lopez-Gitlitz, A; McCarthy, SA; Miladinovic, B; McQuarrie, K; Thomas, S; Zhang, K; Small, EJ

Aggarwal, R (通讯作者)，Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.

PROSTATE CANCER, 2022; 2022 ():

Abstract

Purpose. This randomized phase 2 study sought to assess the treatment effect of a finite duration of apalutamide with and without androgen deprivation......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索